Free Trial
NASDAQ:NBSE

NeuBase Therapeutics (NBSE) Stock Price, News & Analysis

$0.38
0.00 (0.00%)
(As of 05/21/2024 ET)
Today's Range
$0.38
$0.38
50-Day Range
$0.37
$1.07
52-Week Range
$0.36
$4.80
Volume
N/A
Average Volume
67,988 shs
Market Capitalization
$1.43 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
NBSE stock logo

About NeuBase Therapeutics Stock (NASDAQ:NBSE)

NeuBase Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as well as other genetic disorders, and cancer and oncology applications. Its pipeline includes NT0100 for Huntington's disease; NT0200 for myotonic dystrophy type 1; and NT0300 treatment targets the mutated KRAS gene. NeuBase Therapeutics, Inc. is headquartered in Pittsburgh, Pennsylvania.

NBSE Stock Price History

NBSE Stock News Headlines

NeuBase Therapeutics Inc
NeuBase Therapeutics, Inc. (NBSE)
NeuBase Therapeutics Inc (O7P.BE)
CMU halts licensing agreement with NeuBase Therapeutics
NeuBase Therapeutics Inc NBSE
NeuBase Therapeutics, Inc. (NBSE.MX)
Massive Insider Trade At NeuBase Therapeutics
Why Is NeuBase Therapeutics (NBSE) Stock Up 19% Today?
NeuBase Therapeutics (NASDAQ: NBSE)
NeuBase Therapeutics to Explore Strategic Alternatives
Pittsburgh biotech firm amends stock incentive plan
See More Headlines
Receive NBSE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NeuBase Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
12/23/2021
Today
5/22/2024
Next Earnings (Estimated)
5/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:NBSE
Fax
N/A
Employees
37
Year Founded
N/A

Profitability

Net Income
$-4,370,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$11.04 per share

Miscellaneous

Free Float
3,456,000
Market Cap
$1.43 million
Optionable
Not Optionable
Beta
0.81
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

NBSE Stock Analysis - Frequently Asked Questions

How have NBSE shares performed in 2024?

NeuBase Therapeutics' stock was trading at $0.7401 on January 1st, 2024. Since then, NBSE stock has decreased by 48.7% and is now trading at $0.38.
View the best growth stocks for 2024 here
.

When is NeuBase Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 23rd 2024.
View our NBSE earnings forecast
.

How were NeuBase Therapeutics' earnings last quarter?

NeuBase Therapeutics, Inc. (NASDAQ:NBSE) announced its earnings results on Thursday, December, 23rd. The company reported ($4.20) EPS for the quarter, beating analysts' consensus estimates of ($4.60) by $0.40.

When did NeuBase Therapeutics' stock split?

NeuBase Therapeutics's stock reverse split on the morning of Thursday, June 15th 2023. The 1-20 reverse split was announced on Thursday, June 15th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 15th 2023. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of NeuBase Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other NeuBase Therapeutics investors own include Sorrento Therapeutics (SRNE), Dynavax Technologies (DVAX), Ovid Therapeutics (OVID), Advanced Micro Devices (AMD), Enterprise Products Partners (EPD), Flexion Therapeutics (FLXN), Pfizer (PFE), VBI Vaccines (VBIV), AbbVie (ABBV) and Aravive (ARAV).

How do I buy shares of NeuBase Therapeutics?

Shares of NBSE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NBSE) was last updated on 5/22/2024 by MarketBeat.com Staff

From Our Partners